Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02223403
Other study ID # 383967-4
Secondary ID
Status Completed
Phase N/A
First received August 20, 2014
Last updated August 21, 2014
Start date October 2012
Est. completion date May 2014

Study information

Verified date August 2014
Source Brooke Army Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Nitrate-rich beetroot juice supplementation has demonstrated reduced oxygen consumption and submaximal exercise performance in healthy adults. Investigation for similar effects in patients with heart failure has not previously been conducted.

This was a randomized, double-blind, placebo controlled trial. Following ingestion of the active agent or placebo, subjects with systolic heart failure underwent submaximal steady state exercise with gas exchange analysis followed thirty minutes later by a six minute walk test. Second testing sessions were performed ten days.

There were no significant differences in the treatment and placebo arms in average oxygen consumption or six minute walk distance.

In conclusion, in patients with heart failure who have ingested a single dose of nitrate-rich beetroot juice concentrate, there is no significant difference with regard to oxygen consumption during submaximal steady state exercise or six minute walk testing distance.

Further study is warranted to determine the true efficacy of nitrate consumption in this population with adjustments in acute or chronic dosing, exercise duration, or intensity.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Local institutional beneficiaries between the ages of 18 and 80

- Documentation of left ventricular systolic dysfunction with ejection fraction < 40% by any modality within the past six months

- Documentation of New York Heart Association class II or III status.

Exclusion Criteria:

- > 80 years of age

- Unable to adequately or safely perform treadmill exercise

- Pulmonary disease deemed significant enough to be a limitation to exercise

- Greater than moderate stenotic or regurgitant valvular heart disease

- Presence of atrial fibrillation or other uncontrolled arrhythmias

- Uncompensated heart failure

- Continuously paced rhythms

- Pregnant females

- Chronic nitroglycerine use (oral isosorbide di or mono-nitrate, or topical nitroglycerine)

- Phosphodiesterase inhibitor (sildenafil or tadalafil) use within a week

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Intervention

Dietary Supplement:
nitrate-rich beetroot juice
3 ounces of nitrate-rich beetroot juice ingested orally once 90 minutes before exercise interventions of steady state treadmill exercise followed 30 minutes later by six minute walk
nitrate-deplete beetroot juice
3 ounces of nitrate-deplete beetroot juice ingested orally once 90 minutes before exercise interventions of steady state treadmill exercise followed 30 minutes later by six minute walk

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Brooke Army Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary steady state exercise oxygen consumption Subjects performed steady state treadmill walking at a pre-determine submaximal workload. Oxygen consumption was measured for the last 10 minutes. 10 minutes No
Primary six minute walk distance subjects walked at their chosen pace for six minutes on a pre-determined course. Total distance was recorded. six minutes No
See also
  Status Clinical Trial Phase
Completed NCT02026102 - A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs) N/A
Active, not recruiting NCT00949676 - DECIDE-HF: Heart Rate Variability in Heart Failure Patients N/A
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Recruiting NCT05230732 - Neuromodulation of Inflammation and Endothelial Function N/A
Completed NCT04065893 - Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
Completed NCT02946853 - Junctional AV Ablation in CRT-D: JAVA-CRT N/A
Completed NCT00833352 - Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device N/A
Terminated NCT02958098 - My Research Legacy Pilot Study
Enrolling by invitation NCT03984591 - A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure Phase 4
Completed NCT02156583 - Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
Recruiting NCT01566344 - Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes N/A
Withdrawn NCT01127334 - Pilot Study Using Echocardiography to Evaluate Patients With Heart Failure and Dyssynchrony Who Have a CRT-D Device N/A
Completed NCT03534297 - Study of Dapansutrile Capsules in Heart Failure Phase 1
Completed NCT01765400 - Platelet Inhibition in Patients With Systolic Heart Failure Phase 4
Completed NCT01814319 - Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure Phase 2
Recruiting NCT02637167 - GutHeart: Targeting Gut Microbiota to Treat Heart Failure Phase 2
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Completed NCT02084992 - A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure N/A
Completed NCT04937790 - Effects of Postural Balance Exercises in Patients With Heart Failure N/A
Completed NCT04019314 - Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI) N/A